Therapeutic Solutions International, Inc.

OTCPK:TSOI Stock Report

Market Cap: US$1.3m

Therapeutic Solutions International Management

Management criteria checks 4/4

Therapeutic Solutions International's CEO is Tim Dixon, appointed in Mar 2011, has a tenure of 13.83 years. total yearly compensation is $365.00K, comprised of 65.8% salary and 34.2% bonuses, including company stock and options. directly owns 10.99% of the company’s shares, worth $140.81K. The average tenure of the management team and the board of directors is 6 years and 6.7 years respectively.

Key information

Tim Dixon

Chief executive officer

US$365.0k

Total compensation

CEO salary percentage65.8%
CEO tenure13.8yrs
CEO ownership11.0%
Management average tenure6yrs
Board average tenure6.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Tim Dixon's remuneration changed compared to Therapeutic Solutions International's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$2m

Jun 30 2024n/an/a

-US$2m

Mar 31 2024n/an/a

-US$2m

Dec 31 2023US$365kUS$240k

-US$2m

Sep 30 2023n/an/a

-US$3m

Jun 30 2023n/an/a

-US$3m

Mar 31 2023n/an/a

-US$4m

Dec 31 2022US$381kUS$240k

-US$4m

Sep 30 2022n/an/a

-US$4m

Jun 30 2022n/an/a

-US$4m

Mar 31 2022n/an/a

-US$3m

Dec 31 2021US$595kUS$227k

-US$3m

Sep 30 2021n/an/a

-US$2m

Jun 30 2021n/an/a

-US$2m

Mar 31 2021n/an/a

-US$2m

Dec 31 2020US$607kUS$196k

-US$2m

Sep 30 2020n/an/a

-US$2m

Jun 30 2020n/an/a

-US$2m

Mar 31 2020n/an/a

-US$1m

Dec 31 2019US$286kUS$146k

-US$2m

Sep 30 2019n/an/a

-US$2m

Jun 30 2019n/an/a

-US$2m

Mar 31 2019n/an/a

-US$2m

Dec 31 2018US$281kUS$174k

-US$2m

Compensation vs Market: Tim's total compensation ($USD365.00K) is below average for companies of similar size in the US market ($USD642.40K).

Compensation vs Earnings: Tim's compensation has been consistent with company performance over the past year.

CEO

Tim Dixon (66 yo)

13.8yrs

Tenure

US$365,000

Compensation

Mr. Timothy George Dixon, also known as Tim, has been the Chairman and President of MolecuVax, Inc. since 2015. Mr. Dixon has been the Chief Executive Officer, President and Chairman of Therapeutic Solutio...

Leadership Team

NamePositionTenureCompensationOwnership
Timothy Dixon
Chairman13.8yrsUS$365.00k10.99%
$ 140.8k
Feng Lin
Chief Scientific Officer5.3yrsUS$15.00k1.21%
$ 15.5k
James Veltmeyer
Chief Medical Officer6.6yrsUS$75.00k0.72%
$ 9.2k
Famela Ramos
Vice President of Business Developmentno dataUS$15.10k0.12%
$ 1.5k
Serena Robella
Director of Sales4.3yrsno datano data

6.0yrs

Average Tenure

55.5yo

Average Age

Experienced Management: TSOI's management team is seasoned and experienced (6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Timothy Dixon
Chairman13.8yrsUS$365.00k10.99%
$ 140.8k
James Veltmeyer
Chief Medical Officer6.9yrsUS$75.00k0.72%
$ 9.2k
Howard Leonhardt
Member of Scientific Advisory Board5yrsno datano data
Thomas Ichim
Director9yrsno data4.04%
$ 51.7k
Pablo Guzman
Member of Scientific Advisory Boardno datano datano data
Francesco Marincola
Member of Scientific Advisory Board6.5yrsno datano data
J. Mizer
Member of Scientific Advisory Board4.3yrsno datano data
Barry Glassman
Chairman of Scientific Advisory Board11.6yrsno datano data
Boris Minev
Member of Scientific Advisory Board3.9yrsno datano data
Santosh Kesari
Member of Scientific Advisory Board9.3yrsno datano data
Nassir Azimi
Member of Scientific Advisory Board6.7yrsno datano data
Juergen Winkler
Member of Scientific Advisory Board6.5yrsno datano data

6.7yrs

Average Tenure

61.5yo

Average Age

Experienced Board: TSOI's board of directors are considered experienced (6.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/07 19:05
End of Day Share Price 2025/01/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Therapeutic Solutions International, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution